• 1
    Heidenreich A, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis and treatment of clinically localised disease. Eur Urol 2011; 59: 6171
  • 2
    Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 17081717
  • 3
    Jhaveri FM, Zippe CD, Klein EA, Kupelian PA. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 1999; 54: 884890
  • 4
    Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555565
  • 5
    Bianco FJ Jr, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 2005; 66: 8394
  • 6
    Isbarn H, Wanner M, Salomon G et al. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen area. BJU Int 2010; 106: 3743
  • 7
    Kupelian PA, Katcher J, Levin HS, Klein EA. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiat Oncol Biol Phys 1997; 37: 10431052
  • 8
    Stephenson AJ, Shariat SF, Zelefsky MJ et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004; 291: 13251332
  • 9
    Poortmans P, Bossi A, Vandeputte K et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC radiation oncology group. Radiother Oncol 2007; 84: 121127
  • 10
    Connolly JA, Shinohara K, Presti JC Jr, Carroll PR. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996; 47: 225231
  • 11
    Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 2001; 219: 432439
  • 12
    Scattoni V, Roscigno M, Raber M et al. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 2003; 44: 407414
  • 13
    Sella T, Schwartz LH, Swindle PW et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004; 231: 379385
  • 14
    Kessler T, Burkhard FC, Studer UE. Nerve-sparing open radical retropubic prostatectomy. Eur Urol 2007; 51: 9097
  • 15
    Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 1990; 143: 11831187
  • 16
    Epstein JI, Partin AW, Potter SR, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000; 56: 283288
  • 17
    Billis A, Teixeira DA, Stelini RF, Quintal MM, Guimarães MS, Ferreira U. Seminal vesicle invasion in radical prostatectomies: Which is the most common route of invasion? Int Urol Nephrol 2007; 39: 10971102
  • 18
    Cunéo B, Marcille M. Topographie des ganglions ilio-pelviens. Bull Mem Soc Anat, Paris, G. Steinheil 1901; 3: 653663
  • 19
    Van Poppel H, Bolla M, Tombal B et al. Adjuvant radiotherapy after radical prostatectomy in patients with pathologically high risk prostate cancer: 10-year follow-up results. Eur Urol Suppl 2011; 10 (Suppl. 5) 227 [abstract]
  • 20
    Michalsky JM, Lawton C, El Naqa I et al. Development of ROTG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; 76: 361368
  • 21
    Tombal B, Van Cangh PJ, Loric S, Gala JL. Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy. Prostate 2003; 56: 163170
  • 22
    Bellina M, Mari M, Ambu A, Guercio S, Rolle L, Tampellini M. Seminal monolateral nerve-sparing radical prostatectomy in selected patients. Urol Int 2005; 75: 175180
  • 23
    Albers P, Schäfers S, Löhmer H, de Geeter P. Seminal vesicle-sparing perineal radical prostatectomy improves early functional results in patients with low-risk prostate cancer. BJU Int 2007; 100: 10501054
  • 24
    Zlotta AR, Roumeguère T, Ravery V et al. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. Eur Urol 2004; 46: 4249